Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dixtal buys Respironics' pulse oximetry unit:

This article was originally published in Clinica

Executive Summary

Consistent with its strategy to divest non-core technologies, sleep and respiratory disorders company Respironics has sold its Novametrix pulse oximetry business to its long-term Brazilian manufacturing and marketing partner Dixtal Biomedica. Murrysville, Pennsylvania-based Respironics will retain its NICO2, Tidal Wave and CO2SMO pulse oximetry lines. Dixtal, which specialises in multi-parameter monitoring products, made the acquisition through its Dixtal Medical subsidiary. It has been selling the Novametrix products in Brazil for the last 15 years. Financial details of the transaction were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049927

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel